HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Middle East and North Africa  /  MAR

Morocco

Morocco appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

26,000
People living with HIV, 2025
WHO Global Health Observatory
76.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$6k
United States HIV disbursements, 2023
OECD Creditor Reporting System
$6.1m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$-5m$0$5m$10m20022005200820112014201720202023$6.1m$6k$5.9m$6k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $139k — — $15k
2003 $2.4m — $1.9m —
2004 $2.2m — $2.0m —
2005 $3.9m $9k $2.9m $2k
2006 $2.8m $42k $2.4m $36k
2007 $5.8m $91k $4.5m $70k
2008 $4.6m $69k $4.2m $88k
2009 $5.7m $142k $5.0m $94k
2010 $7.2m $161k $5.9m $200k
2011 $8.4m $124k $7.1m $104k
2012 $7.1m $98k $6.2m $124k
2013 $4.3m $25k $3.5m $-38k
2014 $8.4m $10k $8.1m $10k
2015 $1.9m $86k $1.2m —
2016 $6.0m — $5.5m —
2017 $4.7m — $4.1m —
2018 $5.2m $40k $5.0m $40k
2019 $4.4m — $4.2m $83k
2020 $3.4m — $3.4m —
2021 $7.5m — $7.5m —
2022 $11.4m $9k $11.4m $14k
2023 $8.4m $6k $8.2m $6k
2024 $6.1m — $5.9m —

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
010k20k20002003200620092012201520182021202424,00018,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 11,000 8,700 13,000 —
2001 11,000 9,600 14,000 —
2002 12,000 10,000 14,000 —
2003 13,000 11,000 15,000 —
2004 14,000 12,000 16,000 —
2005 15,000 13,000 17,000 —
2006 16,000 14,000 17,000 —
2007 16,000 15,000 18,000 —
2008 17,000 15,000 19,000 —
2009 17,000 16,000 19,000 —
2010 18,000 16,000 20,000 2,800
2011 18,000 17,000 21,000 3,600
2012 19,000 17,000 21,000 4,600
2013 19,000 18,000 22,000 5,700
2014 20,000 18,000 22,000 6,500
2015 20,000 18,000 22,000 7,400
2016 20,000 19,000 23,000 8,300
2017 21,000 19,000 23,000 9,200
2018 21,000 19,000 23,000 10,000
2019 21,000 20,000 24,000 11,000
2020 22,000 20,000 24,000 12,000
2021 22,000 20,000 25,000 15,000
2022 23,000 21,000 25,000 16,000
2023 23,000 21,000 26,000 17,000
2024 24,000 21,000 26,000 18,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%25%50%75%2010201220142016201820202022202480.0%76.0%72.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 33.0% 16.0% 13.0%
2011 36.0% 19.0% 16.0%
2012 41.0% 25.0% 20.0%
2013 47.0% 29.0% 25.0%
2014 54.0% 33.0% 29.0%
2015 59.0% 37.0% 32.0%
2016 61.0% 41.0% 36.0%
2017 68.0% 44.0% 39.0%
2018 74.0% 48.0% 43.0%
2019 76.0% 51.0% 47.0%
2020 80.0% 54.0% 50.0%
2021 81.0% 68.0% 65.0%
2022 77.0% 70.0% 65.0%
2023 78.0% 73.0% 69.0%
2024 80.0% 76.0% 72.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Morocco

1,564 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNAIDS AIDSinfo Modelled estimate 805 30 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 253 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 159 17 2000–2025 extranet.who.int 2026-10-16
Global Fund Data Service Programme record 84 6 2017–2025 fetch.theglobalfund.org 2026-10-12
OECD Creditor Reporting System Expenditure account 59 3 2002–2024 sdmx.oecd.org 2026-10-12
IATI, through d-portal Expenditure account 51 3 2003–2026 d-portal.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
ForeignAssistance.gov Expenditure account 32 4 2002–2023 foreignassistance.gov 2026-10-29
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 30 15 2015–2017 hivfinancial.unaids.org 2026-10-12
WHO HIV testing services dashboard Programme record 26 4 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
UNAIDS Data 2025 country databook Expenditure account 9 3 2015–2017 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
Demographic and Health Surveys Survey 1 1 2003 api.dhsprogram.com 2026-10-16

Indicators held

73 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $108k (2024)
Budget required for collaborative TB/HIV activities Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $108k (2025)
Country-reported HIV expenditure, all sources Financing USD 7 2012–2017 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $39.1m (2017)
Domestic funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $28.9m (2024)
Domestic public HIV expenditure Financing USD 6 2015–2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $18.2m (2017)
Expected Global Fund funding for the national TB programme Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $950k (2025)
Expected USAID funding for the national TB programme Financing USD 5 2018–2022 WHO Global Tuberculosis Programme $0 (2022)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $27.9m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 7 2018–2025 WHO Global Tuberculosis Programme $108k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $6.1m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 12 2005–2025 IATI, through d-portal $431k (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $0 (2026)
External HIV financing from the United States (ODA) Financing USD 29 2002–2023 ForeignAssistance.gov, OECD Creditor Reporting System $6k (2023)
Funding received for collaborative TB/HIV activities Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $108k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 10,375,970 (2026)
Global Fund HIV disbursements to the country Financing USD 48 2003–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $4.0m (2026)
Global Fund funding received by the national TB programme Financing USD 7 2017–2024 WHO Global Tuberculosis Programme $745k (2024)
HIV spending on community mobilisation and system strengthening Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $33k (2016)
HIV spending on critical enablers Financing USD 2 2016–2017 UNAIDS Global AIDS Monitoring expenditure database $1.7m (2017)
HIV spending on gender programmes Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $17k (2016)
HIV spending on governance and sustainability Financing USD 2 2016–2017 UNAIDS Global AIDS Monitoring expenditure database $6.6m (2017)
HIV spending on prevention Financing USD 2 2016–2017 UNAIDS Global AIDS Monitoring expenditure database $10.9m (2017)
HIV spending on prevention of vertical transmission Financing USD 2 2016–2017 UNAIDS Global AIDS Monitoring expenditure database $1.5m (2017)
HIV spending on programmes for children and adolescents Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $530k (2016)
HIV spending on social protection and economic support Financing USD 1 2016 UNAIDS Global AIDS Monitoring expenditure database $1.1m (2016)
HIV spending on treatment, care and support Financing USD 2 2016–2017 UNAIDS Global AIDS Monitoring expenditure database $18.4m (2017)
International HIV expenditure (country-reported) Financing USD 6 2015–2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $19.3m (2017)
Other bilateral HIV expenditure (country-reported) Financing USD 2 2015–2016 UNAIDS Global AIDS Monitoring expenditure database $779k (2016)
Private HIV expenditure (country-reported) Financing USD 6 2015–2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $1.5m (2017)
US HIV disbursements managed by USAID Financing USD 3 2002–2014 ForeignAssistance.gov $0 (2014)
US HIV disbursements managed by other US agencies Financing USD 12 2005–2019 ForeignAssistance.gov $83k (2019)
US HIV disbursements managed by the State Department Financing USD 2 2022–2023 ForeignAssistance.gov $6k (2023)
USAID funding received by the national TB programme Financing USD 6 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 26 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 74.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 76.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 29 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 80.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 17 2008–2024 UNAIDS AIDSinfo 62.9% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2019–2020 UNAIDS AIDSinfo 16.5% (2020)
% of people living with HIV on ART who completed a course of TB preventive therapy Treatment cascade percent 1 2024 UNAIDS AIDSinfo 80.5% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 9 2013–2024 UNAIDS AIDSinfo 91.8% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 7 2015–2024 UNAIDS AIDSinfo 15.5% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 11 2015–2025 WHO Global Health Observatory 97.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 17 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.4% (2024)
HIV tests performed at a health facility Treatment cascade count 3 2019–2022 WHO HIV testing services dashboard 210,595 (2022)
HIV tests performed through community outreach Treatment cascade count 3 2019–2022 WHO HIV testing services dashboard 64,021 (2022)
HIV tests performed with the result returned to the person Treatment cascade count 24 2018–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 1,206,323 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 4 2010–2013 UNAIDS AIDSinfo 32.0% (2013)
HIV-positive TB patients started or continued on ART Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 341 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 27 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 6 2015–2020 UNAIDS AIDSinfo 48.0% (2020)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 77 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 19,880 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 15 2010–2024 UNAIDS AIDSinfo 72.0% (2024)
People newly enrolled on ART during the year Treatment cascade count 9 2013–2024 WHO Global Tuberculosis Programme 364 (2024)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 6 2017–2022 UNAIDS AIDSinfo 16.0% (2022)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 262 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 364 (2024)
TB patients with an HIV test result recorded Treatment cascade count 15 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 17,474 (2025)
AIDS-related deaths Epidemic estimates count 201 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 500 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 89 (2024)
HIV prevalence among a key population Epidemic estimates percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.1% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 530 (2024)
New HIV infections Epidemic estimates count 201 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 1,100 (2025)
People living with HIV Epidemic estimates count 201 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 26,000 (2025)
Key-population members reached by prevention programmes Prevention and outreach percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 27 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 4 2019–2023 UNAIDS AIDSinfo 5,000,000 (2023)
People receiving PrEP Prevention and outreach count 4 2018–2022 UNAIDS AIDSinfo 740 (2022)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 1 2003 Demographic and Health Surveys By population group, sex or age only, to 2003
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 530 (2025)
Estimated size of a key population Population denominators count 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 38,430,770 (2025)
Share of HIV-exposed infants who acquire HIV — percent 15 2010–2024 UNAIDS AIDSinfo 12.0% (2024)

Every row shown on the Morocco page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.